qnrA6 genetic environment and quinolone resistance conferred on Proteus mirabilis

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 4, 2016, Pages 903-908

  Jayol, Aurélie ^a,b   Janvier, Frédéric ^a,c   Guillard, Thomas ^a,d,e   Chau, Françoise ^a   Mérens, Audrey ^f   Robert, Jérôme ^g   Fantin, Bruno ^a   Berçot, Béatrice ^a,b   Cambau, Emmanuelle ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Military Teaching Hospital Sainte Anne   (France)

^d SERVICE DE DERMATOLOGIE   (France)

^e UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^f SERVICE D ENDOCRINOLOGIE   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GENOMIC DNA; LEVOFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PLASMID DNA; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; CONTROLLED STUDY; ESCHERICHIA COLI; GENE LOCATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEUS MIRABILIS; QNRA6 GENE; BACTERIAL CHROMOSOME; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; PLASMID;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHROMOSOMES, BACTERIAL; CLONING, MOLECULAR; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEUS MIRABILIS; QUINOLONES;

EID: 84964336643     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv431     Document Type: Article

References (36)

1. Cambau E, Guillard T. Antimicrobials that affect the synthesis and conformation of nucleic acids. Rev Sci Tech 2012; 31: 77-87.
2. Hooper DC, Mandell GL, Douglas RG et al. Quinolones. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th edn. Philadelphia: Elsevier Churchill Livingstone, 2005; 451-67.
3. Park CH, Robicsek A, Jacoby GA et al. Prevalence in the United States of aac(6')-Iβ-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006; 50: 3953-5.
4. Tran JH, Jacoby GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA 2002; 99: 5638-42.
5. Robicsek A, Strahilevitz J, Jacoby GA et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 2006; 12: 83-8.
6. Machuca J, Briales A, Diaz-de-Alba P et al. Effect of the efflux pump QepA2 combined with chromosomally mediated mechanisms on quinolone resistance and bacterial fitness in Escherichia coli. J Antimicrob Chemother 2015; 70: 2524-7.
7. Cambau E, Lascols C, Sougakoff W et al. Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005. Clin Microbiol Infect 2006; 12: 1013-20.
8. Sana F, Mabrouka S, Claudine Q et al. Prevalence and characterization of uropathogenic Escherichia coli harboring plasmid-mediated quinolone resistance in a Tunisian university hospital. Diagn Microbiol Infect Dis 2014; 79: 247-51.
9. Mahrouki S, Chihi H, Bourouis A et al. Nosocomial dissemination of plasmids carrying blaTEM-24, blaDHA-1, aac(6')-Iβ-cr, and qnrA6 in Providencia spp. strains isolated from a Tunisian hospital. Diagn Microbiol Infect Dis 2015; 81: 50-2.
10. Dahmen S, Poirel L, Mansour Wet al. Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from Tunisia. Clin Microbiol Infect 2010; 16: 1019-23.
11. Mahrouki S, Chihi H, Bourouis A et al. First characterization of a Providencia stuartii clinical isolate from a Tunisian intensive care unit coproducing VEB-1-a, OXA-2, qnrA6 and aac(6')-Iβ-cr determinants. Braz J Infect Dis 2014; 18: 211-4.
12. Zujic Atalic V, Bedenic B, Kocsis E et al. Diversity of carbapenemases in clinical isolates of Enterobacteriaceae in Croatia-the results of a multicentre study. Clin Microbiol Infect 2014; 20: O894-903.
13. Mnif B, Ktari S, Chaari A et al. Nosocomial dissemination of Providencia stuartii isolates carrying blaOXA-48, blaPER-1, blaCMY-4 and qnrA6 in a Tunisian hospital. J Antimicrob Chemother 2013; 68: 329-32.
14. Barguigua A, El Otmani F, Talmi M et al. Prevalence and genotypic analysis of plasmid-mediated β-lactamases among urinary Klebsiella pneumoniae isolates in Moroccan community. J Antibiot (Tokyo) 2013; 66: 11-6.
15. Arpin C, Thabet L, Yassine H et al. Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit. Antimicrob Agents Chemother 2012; 56: 1342-9.
16. Guillard T, Cambau E, Neuwirth C et al. Description of a 2, 683-base-pair plasmid containing qnrD in two Providencia rettgeri isolates. Antimicrob Agents Chemother 2012; 56: 565-8.
17. Lascols C, Robert J, Cattoir V et al. Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene. Int J Antimicrob Agents 2007; 29: 402-9.
18. Guillard T, de Champs C, Moret H et al. High-resolution melting analysis for rapid characterization of qnr alleles in clinical isolates and detection of two novel alleles, qnrB25 and qnrB42. J Antimicrob Chemother 2012; 67: 2635-9.
19. Guillard T, Duval V, Moret H et al. Rapid detection of aac(6')-Iβ-cr quinolone resistance gene by pyrosequencing. J Clin Microbiol 2010; 48: 286-9.
20. Guillard T, Moret H, Brasme L et al. Rapid detection of qnr and qepA plasmid-mediated quinolone resistance genes using real-time PCR. Diagn Microbiol Infect Dis 2011; 70: 253-9.
21. de Champs C, Monne C, Bonnet R et al. New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates. Antimicrob Agents Chemother 2001; 45: 1278-80.
22. Poirel L, Cabanne L, Vahaboglu H et al. Genetic environment and expression of the extended-spectrum β-lactamase blaPER-1 gene in gramnegative bacteria. Antimicrob Agents Chemother 2005; 49: 1708-13.
23. Poirel L, Rodriguez-Martinez JM, Mammeri H et al. Origin of plasmidmediated quinolone resistance determinant QnrA. Antimicrob Agents Chemother 2005; 49: 3523-5.
24. Bogaerts P, Bouchahrouf W, de Castro RR et al. Emergence of NDM-1-producing Enterobacteriaceae in Belgium. Antimicrob Agents Chemother 2011; 55: 3036-8.
25. Wang M, Tran JH, Jacoby GA et al. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003; 47: 2242-8.
26. Rodriguez-Martinez JM, Poirel L, Canton R et al. Common region CR1 for expression of antibiotic resistance genes. Antimicrob Agents Chemother 2006; 50: 2544-6.
27. Lascols C, Podglajen I, Verdet C et al. A plasmid-borne Shewanella algae gene, qnrA3, and its possible transfer in vivo between Kluyvera ascorbata and Klebsiella pneumoniae. J Bacteriol 2008; 190: 5217-23.
28. Case CC, Roels SM, Gonzalez JE et al. Analysis of the promoters and transcripts involved in IS10 anti-sense RNA control. Gene 1988; 72: 219-36.
29. Arduino SM, Roy PH, Jacoby GA et al. blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513. Antimicrob Agents Chemother 2002; 46: 2303-6.
30. Toleman MA, Bennett PM, Walsh TR. ISCR elements: novel genecapturing systems of the 21st century? Microbiol Mol Biol Rev 2006; 70: 296-316.
31. Xia R, Guo X, Zhang Y et al. qnrVC-like gene located in a novel complex class 1 integron harboring the ISCR1 element in an Aeromonas punctata strain from an aquatic environment in Shandong Province, China. Antimicrob Agents Chemother 2010; 54: 3471-4.
32. Jacoby GA, Strahilevitz J, Hooper DC. Plasmid-mediated quinolone resistance. Microbiol Spectr 2014; 2 doi:10.1128/microbiolspec.PLAS-0006-2013.
33. Wang M, Sahm DF, Jacoby GA et al. Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmidmediated quinolone resistance determinant qnr. Antimicrob Agents Chemother 2004; 48: 1400-1.
34. Merens A, Matrat S, Aubry A et al. The pentapeptide repeat proteins MfpAMt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex. J Bacteriol 2009; 191: 1587-94.
35. Guo Q, Weng J, Xu X et al. A mutational analysis and molecular dynamics simulation of quinolone resistance proteins QnrA1 and QnrC from Proteus mirabilis. BMC Struct Biol 2010; 10: 33.
36. Weigel LM, Anderson GJ, Tenover FC. DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis. Antimicrob Agents Chemother 2002; 46: 2582-7.